Cencora

Cencora is a pharmaceutical services company that focuses on the distribution of prescription drugs and related healthcare products. It operates as a wholesale intermediary between pharmaceutical manufacturers and various healthcare providers, including hospitals, retail pharmacies, and long‑term care facilities. The company also offers a range of value‑added services such as inventory management, data analytics, and patient support programs. These activities are intended to streamline the supply chain and improve access to medications for end users.

Headquartered in the United States, Cencora is one of the largest drug wholesalers operating nationally, with a footprint that extends across all fifty states. It is consistently ranked among the Fortune 500 corporations, reflecting its substantial scale within the healthcare sector. The company’s network includes numerous distribution centers and a logistics infrastructure designed to handle temperature‑sensitive and regulated pharmaceutical products. Its customer base encompasses a broad spectrum of healthcare organizations that rely on its services for timely and secure product delivery.

Cencora’s distinguishing attributes lie in its specialization in pharmaceutical supply chain management and its adherence to stringent regulatory standards governing drug distribution. The firm leverages competencies in cold‑chain handling, track‑and‑trace technology, and regulatory reporting to support compliance with FDA and DEA requirements. It was formerly known as AmerisourceBergen and underwent a rebranding to Cencora in 2023 to reflect its expanded services beyond traditional wholesale. In February 2024 the company disclosed a cybersecurity incident involving unauthorized access to its information systems, which prompted a standard breach notification process.